Search
-
Searchresult: Walther and Christine Richtzenhain Foundation
Recognizing successes in cancer research The Richtzenhain Foundation promotes cancer research in accordance with the will of the founders by awarding two prizes alternately each year. In one year,…
-
Searchresult: Andreas Zimprich Foundation
Supporting brain tumor research Andreas Zimprich died of a brain tumor at the age of 48. His parents Marianne and Egon Zimprich founded the Andreas Zimprich Foundation in his memory together with…
-
Searchresult: Andreas Wörner Foundation
Preserving memory and advancing cancer research In memory of her son Andreas Wörner, who died of cancer, Christa Wörner established a dependent, fiduciary foundation under the umbrella of the German…
-
Searchresult: Rainer Hoenig Foundation
Research in the field of bile duct cancer In memory of her husband Rainer Hoenig, who died in 2018 as a result of bile duct cancer, his widow Hedvig Hoenig, née Schmidt, established the Rainer…
-
Searchresult: KiTZ Foundation in memory of Kirstin Diehl
Outstanding commitment to children's cancer research The foundation was established in 2006 by Gerd and Gerda Diehl as the Kirstin Diehl Foundation in memory of their daughter Kirstin and was…
-
Searchresult: FAQs on wills
FAQ Inheritances DKFZ You can also download the most frequently asked questions about inheritance and bequests as a PDF file here. Your contact person You are also welcome to contact us…
-
Searchresult: Will brochure
We’ll be happy to provide any information you need if you send us an e-mail to nachlass@dkfz.de You can order the will brochure on the German page. You can find key information…
-
Searchresult: Previous Publications
-
Searchresult: Research Group Lipid Pathobiochemistry
PD Dr. Roger Sandhoff Within our research group “Lipid Pathobiochemistry” we investigate the endogenous and pathological functions of sphingolipids. Sphingolipids are a complex class of membrane…
-
Searchresult: Klinische_Studien_02_2025.pdf
Version 2/2025 Klinische Studien - mit möglichem Studieneinschluss Clinical trials - with possible study inclusion R3767-ONC-2011 A Phase 3 Trial of Fianlimab (REGN3767,ANTI-LAG-3) + Cemiplimab…
Document